News

Infosys’ Nandan Nilekani, Deepinder Goyal of Eternal, Mukesh Ambani of Reliance Industries, Murli Krishnan Prasad Divi of ...
India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...
According to an exchange filing, the inspection was conducted from 28 July to 1 August 2025. The company reported that the ...
Torrent Pharmaceuticals reported a 20% increase in net profit to Rs 548 crore for Q1 FY26, driven by robust performance ...
Revenue grew 11.2% to ₹3,178 crore from ₹2,859 crore a year ago, supported by continued momentum in the company’s India and Brazil businesses. EBITDA for the quarter stood at ₹1,032 crore, marking a ...
Torrent Pharmaceuticals reported a 20% year-on-year increase in net profit to Rs 548 crore for the June quarter, driven by ...
New Delhi: Torrent Pharmaceuticals on Monday said its consolidated net profit increased 20 per cent year-on-year to Rs 548 ...
Torrent Pharmaceuticals is planning to release oral and injectable versions of the weight loss drug, semaglutide, following the expiration of Novo Nordisk's patent.
Torrent Pharmaceuticals posted a steady set of numbers in the fourth quarter, reinforcing confidence in its growth trajectory and catching the attention of SEBI-registered analyst Lalit Mundhra ...
Indian drugmaker Mankind Pharma reported a lower first-quarter profit on Thursday, as mounting expenses outpaced strong ...
Torrent Pharmaceuticals Ltd. has lined up at least $5 billion in funding as the company is seeking to buy a stake in Mumbai-listed drugmaker Cipla Ltd., according to people familiar with the matter.
Torrent Pharmaceuticals is recalling an additional 104 lots of losartan blood pressure tablets, according to an FDA notice. The recall includes both losartan potassium tablets and losartan ...